Clinical
RSSArticles
-
ID Grand Rounds — Stanford University
A 69-year-old male with allogeneic hematopoietic stem cell transplant with a space-occupying lesion of the central nervous system.
-
Tissue Invasion by Malignantly Transformed Cells from Hymenolepis nana in a Human Host
The first reported case of human disease caused by parasite-derived cancer cells was discovered in a 41-year-old man with HIV infection; lung, adrenal, and liver nodules; and lymphadenopathy.
-
Outcomes of Acute Encephalitis in Children
ABSTRACT & COMMENTARY: MRI is useful not only in assisting with identifying the etiology of encephalitis, but also provides prognostic information.
-
Immediate Postpartum IUD Insertion: Ready for Prime Time?
It is no secret that long-acting reversible contraception, such as intrauterine devices and implants, are among the most effective methods.
-
Screening for Fetal Chromosome Abnormalities: What Combination Makes the Most Sense?
Recent studies using data from the California Prenatal Screening Program show that standard screening protocols, which combine first trimester ultrasound and biochemistry with second trimester biochemistry, has a very acceptable detection rate and outperforms NIPT in cost-effectiveness in low-risk patients.
-
Urinary Urge Incontinence and Pelvic Floor Physical Therapy
Pelvic floor physical therapy with myofascial release techniques improves urinary symptoms and provides an alternate option to medications and more invasive therapies.
-
Should Postmenopausal Women Be Encouraged to Take Calcium?
A systematic review of randomized, controlled trials of calcium supplementation found only small non-progressive increases in bone mineral density. This supports the clinical conclusion that supplementation alone is insufficient to prevent fracture risk.
-
Should We Remove Every Woman’s Fallopian Tubes?
This article discusses the role of salpingectomy for the prevention of ovarian and fallopian tube cancer.
-
Left Ventricular Assist Devices for Ambulatory Heart Failure: Weighing the Risks and Benefits
Recent data support the use of the HeartMate II left ventricular assist devices in functionally limited, non-inotrope-dependent heart failure patients who have poor quality of life and meet FDA criteria for destination therapy LVAD.
-
Utility of Non-traditional Risk Factors
Adding additional risk factors not in the pooled risk equation to low-risk subjects identified a sub-group with an observed event rate > 7.5% who may warrant statin therapy.